PHARMA News

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Sep 2 05:33 ET

PHARMA: Change in Boardroom - ENCIK ZULKIFLI BIN JAFAR

Aug 30 05:36 ET

PHARMA: Quarterly rpt on consolidated results for the financial period ended 30/06/2024

Aug 21 06:08 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Aug 1 05:38 ET

PHARMA: Change in Boardroom - DR MARY JANE CARDOSA

Jul 19 05:34 ET

PHARMA: Change in Boardroom - DATO’ SERI DR HJ AWALUDIN BIN SAID

Jul 19 05:33 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jul 1 00:48 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jun 5 00:47 ET

PHARMA: General Meetings: Outcome of Meeting

Jun 5 00:45 ET

Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)

May 27 01:58 ET

PHARMA: Quarterly rpt on consolidated results for the financial period ended 31/03/2024

May 27 01:07 ET

PHARMA: Change in Boardroom - ENCIK MOHD FIRDAUS BIN ZULKIFLI

May 20 05:43 ET

PHARMA: AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : MATERIAL UNCERTAINTY RELATED TO GOING CONCERN

May 8 07:19 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

May 2 05:33 ET

PHARMA: General Meetings: Notice of Meeting (Amended Announcement)

May 2 05:20 ET

PHARMA: General Meetings: Notice of Meeting

May 2 00:36 ET

PHARMA: Annual Report & CG Report - 2023

Apr 29 06:15 ET

PHARMA: CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE

Apr 29 06:09 ET

PHARMA: TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS

Apr 23 01:06 ET

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Apr 2 06:07 ET